{"name":"Cyclarity Therapeutics, Inc.","slug":"cyclarity-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOWm1aaHY4VlhDN19GaVZCVHRyOTdJeTZLN2d5endJdVROaDZfRzJVU2l3clRWRWZ0WFVyQnB2NHI4R1ZMWVd6djJoaWJEYkJhNUtOc1hYblpFbm9ub0sxU0pGMjRiRFgwczA4TnNGdkk5UElPSnlvTWVxVllVcjAxcUlvOFJPOWRZYm0wV2gtNFVIczhqZ240?oc=5","date":"2025-11-08","type":"pipeline","source":"TCTMD.com","summary":"CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia - TCTMD.com","headline":"CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNeHdRZ2c1TW8ydXZfMjUwdEt2V1Q2LS1tQzlDV1I0UU1ibUtxZExqdXJkR2ZVUGQwZVB4MGJHZ0ViQVd5LWdJbGlEX1prUDJOTlFkUkoxOVRhTmZTX1hVRmJHS1I4WE5LOWdPYXRIelhDMEIyOTIycUhsNTFNMlIxajRMZjRxSHpUSGtPdW1lNHM0b3JWQ0hKbldtRzBZQjBtRVE?oc=5","date":"2025-07-28","type":"trial","source":"Longevity.Technology","summary":"New data supports Cyclarity’s approach to atherosclerosis reversal - Longevity.Technology","headline":"New data supports Cyclarity’s approach to atherosclerosis reversal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPU3NPbjZfQmFpZWY0UzdWbTdtdmp5TWlDTWN5SHlib0RwN3VfNDJpclh5b0hjZ0czbU01RktXaWhoekZGdWxLejk0Q3RiU0NhSE1pcWI2OUFCeFNKTm9KZjJCU1VPTWVtOVdIU2lBdTFRbFNMcTBpdmJjUE5wdkRpSUJiZFJHSHc?oc=5","date":"2025-01-23","type":"trial","source":"Lifespan Research Institute","summary":"Cyclarity Launches Human Trial to Cure Atherosclerosis - Lifespan Research Institute","headline":"Cyclarity Launches Human Trial to Cure Atherosclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPS0d6aDZOdXNzOHQtNW1BMGpzZm5CTk9hYlh3SURDcXpNa010M2ltelFxYzVNZEZNVEQyMWhEdnl1SW15eUhheURyaEVHTG1BY0ZLME51bmVtSG9UY3hSdGxrNmdLZjdYbjhXd0ZkSHVoZm8xRGVJUnFka3lHRnNGMUJwa0UxUHhKWmRfRWU1b3g4bDl0aTd4TA?oc=5","date":"2022-06-24","type":"pipeline","source":"Longevity.Technology","summary":"Underdog becomes Cyclarity – and moves to the Buck Institute - Longevity.Technology","headline":"Underdog becomes Cyclarity – and moves to the Buck Institute","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}